您的位置: 首页 > 农业专利 > 详情页

VITREOLYSE PHARMACOLOGIQUE
专利权人:
THROMB-X NV
发明人:
PAKOLA, STEVE,DE SMET, MARC
申请号:
CA2508606
公开号:
CA2508606C
申请日:
2003.12.05
申请国别(地区):
CA
年份:
2015
代理人:
摘要:
A method of treating or preventing a disorder, or a complication of adisorder, of an eye of a subject comprising contacting a vitreous and/oraqueous humor with a composition comprising a truncated form of plasmincomprising a catalytic domain of plasmin (TPCD). TPCDs include, but are notlimited to, miniplasmin, microplasmin and derivatives and variants thereof.The methods of the invention can be used to reduce the viscosity of thevitreous, liquefy the vitreous, induce posterior vitreous detachment, reducehemorrhagic blood from the eye, clear or reduce materials toxic to the eye,clear or reduce intraocular foreign substances from the eye, increasediffusion of a composition administered to an eye, reduce extraretinalneovascularization and any combinations thereof. The method can be used in theabsence of, or as an adjunct to, vitrectomy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充